Clinical and neuropsychological effects of the novel antidepressant bupropion
Clay, T.H.; Gualtieri, C.T.; Evans, R.W.; Gullion, C.M.
Psychopharmacology Bulletin 24(1): 143-148
1988
ISSN/ISBN: 0048-5764 PMID: 3133717 Document Number: 311330
Document emailed within 1 workday
Related Documents
Stern, W.C.; Harto-Truax, N.; Rogers, J.; Miller, L. 1982: Clinical profile of the novel antidepressant bupropion Advances in Biochemical Psychopharmacology 32: 21-34Halaris, A.E.; Stern, W.; Harto-Truax, N. 1981: Clinical efficacy of the new antidepressant bupropion (Wellbutrin) Psychopharmacology Bulletin 17(1): 140-142
Stern, W.C.; Harto-Truax, N. 1980: Two multicenter studies of the antidepressant effects of bupropion HCl versus placebo Psychopharmacology Bulletin 16(3): 43-46
El-Dakhakhny, M.; Abdel el-Latif, H.A.; Ammon, H.P. 1996: Different effects of the antidepressant drugs imipramine, maprotiline and bupropion on insulin secretion from mouse pancreatic islets Arzneimittel-Forschung 46(7): 667-669
Itil, T.M.; Cora, R.; Hsu, W.; Gig, E.; Saletu, B. 1972: Clinical, toxicological and electroencephalographical effects of a new tricyclic antidepressant, OI-77 Arzneimittel-Forschung 22(12): 2063-2066
Harto-Truax, N.; Stern, W.C.; Miller, L.L.; Sato, T.L.; Cato, A.E. 1983: Effects of bupropion on body weight Journal of Clinical Psychiatry 44(5 Part 2): 183-186
Gao, L.-C.; Huang, X.; Tan, Z.-R.; Fan, L.; Zhou, H.-H. 2012: The effects of sodium ferulate on the pharmacokinetics of bupropion and its active metabolite in healthy men European Review for Medical and Pharmacological Sciences 16(9): 1192-1196
Ferry, L.; Johnston, J.A. 2003: Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience International Journal of Clinical Practice 57(3): 224-230
McCombs, J.S.; Nichol, M.B.; Stimmel, G.L.; Sclar, D.A.; Beasley, C.M.; Gross, L.S. 1990: The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population Journal of Clinical Psychiatry 51 Suppl: 60-69; Discussion: 70-71
Regestein, Q.R.; Friebely, J.; Shifren, J.; Schiff, I. 2001: Neuropsychological effects of methyltestosterone in women using menopausal hormone replacement Journal of Women's Health and Gender-Based Medicine 10(7): 671-676
Holguin, A.; Banda, M.; Willen, E.J.; Malama, C.; Chiyenu, K.O.; Mudenda, V.C.; Wood, C. 2011: HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia Aids and Behavior 15(8): 1895-1901
Brügmann, M.; Schläger, A.; Schubert, A.; Ammon, I.; Neuser, J. 1998: Neuropsychological effects of preventive CNS irradiation in adult tumor patients Psychotherapie Psychosomatik Medizinische Psychologie 48(9-10): 375-380
Aberg-Wistedt, A. 1989: The antidepressant effects of 5-HT uptake inhibitors British Journal of Psychiatry. Suppl 8: 32-40
Ueda, N.; Nakamura, J. 2001: Side effects and its countermeasures of antidepressant Nihon Rinsho. Japanese Journal of Clinical Medicine 59(8): 1535-1538
Holm, H.; Luutonen, S.; Porela, P. 2001: Cardiac effects of antidepressant agents Duodecim; Laaketieteellinen Aikakauskirja 117(13): 1305-1310
Monuteaux, M.C.; Spencer, T.J.; Faraone, S.V.; Wilson, A.M.; Biederman, J. 2007: A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder Journal of Clinical Psychiatry 68(7): 1094-1101
Flicker, C. 1988: Neuropsychological evaluation of treatment effects in the elderly: a critique of tests in current use Psychopharmacology Bulletin 24(4): 535-556
Kolik, L.G. 2011: Experimental study of antidepressant effects of GB-115 dipeptide Eksperimental'naia i Klinicheskaia Farmakologiia 74(1): 3-5
Gaillard, J.M.; de St Hilaire-Kafi, S. 1985: Sleep, depression and the effects of antidepressant drugs Acta Psychiatrica Belgica 85(5): 561-567
Rosen, W.G. 1983: Clinical and neuropsychological assessment of Alzheimer disease Advances in Neurology 38: 51-64